Trial Profile
Assessment of the Taste Properties of Atazanavir and Cobicistat and Pediatric Oral Test Formulations Containing Both Atazanavir and Cobicistat in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jan 2022
Price :
$35
*
At a glance
- Drugs Atazanavir/cobicistat (Primary) ; Atazanavir; Cobicistat
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 15 Dec 2021 Status changed from active, no longer recruiting to completed.
- 15 Feb 2018 Planned End Date changed from 31 Jul 2018 to 21 Apr 2020.
- 15 Feb 2018 Planned primary completion date changed from 30 Jul 2018 to 20 Apr 2020.